Qingjiang Chen - Concepedia

Author

Qingjiang Chen

First Affiliated Hospital of Zhengzhou University

Also Known As

QINGJIANG CHEN, Qing-Jiang Chen, Qing-jiang Chen, Qingjiang Chen

Publications

487

Citations

H-Index

Concepts

All Affiliations

First Affiliated Hospital of Zhengzhou University China Medical University Charles Sturt University

About

Qingjiang Chen is an author at First Affiliated Hospital of Zhengzhou University specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	206
2	Cell Biology	3	3	53
3	Immunology	2	2	38
4	Pathology	2	2	165
5	Autoimmunity	1	1	26

Qingjiang Chen

Publications

423

Citations

H-Index

Page 1

	Year	Citations
miR-137 Is Frequently Down-Regulated in Gastric Cancer and Is a Negative Regulator of Cdc42 Qingjiang Chen, Xiaobing Chen, Mingzhi Zhang, Digestive Diseases and Sciences Negative RegulatorMedicinePathologyGastric CancerSmall Rna	2011	139
Gensenoside Rg3 Inhibits Hypoxia-induced VEGF Expression in Human Cancer Cells Qingjiang Chen, Mingzhi Zhang, Lexin Wang Cellular Physiology and Biochemistry	2010	79
Increased Nanog Expression Promotes Tumor Development and Cisplatin Resistance in Human Esophageal Cancer Cells Li Yang, Xudong Zhang, Mingzhi Zhang, Cellular Physiology and Biochemistry	2012	39
MicroRNA-155 is a potential molecular marker of natural killer/T-cell lymphoma Xu Dong Zhang, Weiguo Ji, Ruixia Huang, Oncotarget Lymphoid NeoplasiaCancer ImmunosurveillanceNatural Killer/t-cell LymphomaNormal Nk CellsMedicine	2016	26
Patients over 40 years old with precursor T-cell lymphoblastic lymphoma have different prognostic factors comparing to the youngers Meng Dong, Xudong Zhang, Zhenzhen Yang, Scientific Reports	2018	21
Human immunodeficiency virus-negative plasmablastic lymphoma Li Lin, Xudong Zhang, Meng Dong, Medicine	2017	18
Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure Junxia Hu, Xin Wang, Fei Chen, Frontiers in Oncology	2021	17
GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway Zeyuan Wang, Xianting Ran, Siyu Qian, Archives of Biochemistry and Biophysics Tumor BiologyLymphoid NeoplasiaSignaling PathwayMedicineCancer Cell Biology	2021	15
Wnt5a expression in the hindgut of fetal rats with chemically induced anorectal malformations—studies in the ETU rat model Huimin Jia, Qingjiang Chen, Tao Zhang, International Journal of Colorectal Disease Developmental BiologyMammalian PhysiologyFetal RatsPhysiologyMorphogenesis	2011	14
Effects of microRNA-21 on the biological functions of T-cell acute lymphoblastic lymphoma/leukemia Cunzhen Shi, Xudong Zhang, Xin Li, Oncology Letters Tumor BiologyMir-21 ExpressionMixed-phenotype Acute LeukemiaT-regulatory CellImmunology	2016	12

Page 1